Abstract
In this issue of Blood, Loo et al report results from the fourth prospective randomized trial of a putative fms-like tyrosine kinase 3 (FLT3) inhibito......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
